Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Rathlin Therapeutics Limited
Rathlin Therapeutics Limited is an active company incorporated on 23 September 2022 with the registered office located in London, City of London. Rathlin Therapeutics Limited was registered 2 years 11 months ago.
Watch Company
Status
Active
Active since
incorporation
Company No
14373522
Private limited company
Age
2 years 11 months
Incorporated
23 September 2022
Size
Micro
Turnover is under
£1M
Under
10 employees
Confirmation
Due Soon
Dated
22 September 2024
(11 months ago)
Next confirmation dated
22 September 2025
Due by
6 October 2025
(28 days remaining)
Last change occurred
11 months ago
Accounts
Due Soon
For period
23 Sep
⟶
31 Dec 2023
(1 year 3 months)
Accounts type is
Small
Next accounts for period
31 December 2024
Due by
30 September 2025
(22 days remaining)
Learn more about Rathlin Therapeutics Limited
Contact
Address
6th Floor One London Wall
London
EC2Y 5EB
United Kingdom
Same address since
incorporation
Companies in EC2Y 5EB
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
4
Shareholders
14
Controllers (PSC)
1
Dr Mary Brigid Kerr
Director • British • Lives in UK • Born in Oct 1961
Dr Iain Dukes
Director • English • Lives in United States • Born in Jun 1958
Geert-Jan Mulder
Director • Investment Manager • Dutch • Lives in Netherlands • Born in Jul 1966
Julen Oyarzabal
Director • Spanish • Lives in Spain • Born in Oct 1970
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Rawlings Holdings Ltd
Dr Mary Brigid Kerr is a mutual person.
Active
Nerre Therapeutics Ltd
Dr Mary Brigid Kerr is a mutual person.
Active
Causeway Life Sciences Consultants Ltd
Dr Mary Brigid Kerr is a mutual person.
Active
Nerre Therapeutics Holdings Limited
Dr Mary Brigid Kerr is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2023–2023)
Period Ended
31 Dec 2023
For period
31 Dec
⟶
31 Dec 2023
Traded for
12 months
Cash in Bank
£4.36M
Turnover
Unreported
Employees
1
Total Assets
£7.95M
Total Liabilities
-£407.86K
Net Assets
£7.54M
Debt Ratio (%)
5%
See 10 Year Full Financials
Latest Activity
Notification of PSC Statement
5 Months Ago on 10 Apr 2025
Dr Mary Brigid Kerr Details Changed
5 Months Ago on 1 Apr 2025
Mary Brigid Kerr (PSC) Resigned
5 Months Ago on 17 Mar 2025
Julen Oyarzabal Details Changed
7 Months Ago on 13 Jan 2025
Dr Mary Brigid Kerr Details Changed
11 Months Ago on 25 Sep 2024
Confirmation Submitted
11 Months Ago on 25 Sep 2024
Small Accounts Submitted
1 Year 2 Months Ago on 28 Jun 2024
Dr Mary Brigid Kerr Details Changed
1 Year 4 Months Ago on 1 May 2024
Mary Brigid Kerr (PSC) Appointed
1 Year 5 Months Ago on 12 Mar 2024
Notification of PSC Statement
1 Year 11 Months Ago on 12 Oct 2023
Get Alerts
Get Credit Report
Discover Rathlin Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Statement of capital following an allotment of shares on 27 August 2025
Submitted on 3 Sep 2025
Statement of capital following an allotment of shares on 22 July 2025
Submitted on 24 Jul 2025
Director's details changed for Dr Mary Brigid Kerr on 1 April 2025
Submitted on 10 Jul 2025
Notification of a person with significant control statement
Submitted on 10 Apr 2025
Cessation of Mary Brigid Kerr as a person with significant control on 17 March 2025
Submitted on 10 Apr 2025
Statement of capital following an allotment of shares on 17 March 2025
Submitted on 21 Mar 2025
Director's details changed for Julen Oyarzabal on 13 January 2025
Submitted on 27 Feb 2025
Confirmation statement made on 22 September 2024 with updates
Submitted on 25 Sep 2024
Director's details changed for Dr Mary Brigid Kerr on 25 September 2024
Submitted on 25 Sep 2024
Statement of capital following an allotment of shares on 16 July 2024
Submitted on 23 Jul 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs